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What is known about this topic 
Attention-deficit/hyperactivity disorder (ADHD) affects 3 to 5% of children and young people 
in the community in the United Kingdom. 
 
There is a discrepancy between the community prevalence of ADHD and the clinically 
recorded prevalence, which is less than 1%. 
 
Estimates of how the clinically recorded prevalence of ADHD varies by deprivation and 
region are lacking. 
 
What this study adds 
The clinically recorded prevalence of ADHD in children and young people was twice as high 
in the most compared to the least deprived areas. 
 
The greatest inequality in recorded prevalence of ADHD was in the East of England and the 
least inequality was in London. 
 
There is a greater need for health and educational services for children with ADHD in more 
disadvantaged areas. 
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Abstract 
Background In England, there is a discrepancy between the prevalence of Attention-
deficit/hyperactivity disorder (ADHD) ascertained from medical records and community 
surveys. There is also a lack of data on variation in recorded prevalence by deprivation and 
geographical region; information that is important for service development and 
commissioning.  
 
Methods Cohort study using data from the Clinical Practice Research Datalink comprising 
5,196 children and young people aged 3-17 years with ADHD and 490,016 without, in 2012.  
 
Results In 2012, the recorded prevalence (95%CI) of ADHD was 1.06 (1.03-1.09) %. 
Prevalence in the most deprived areas was double that of the least deprived areas 
(prevalence rate ratio (PRR) 2.58 (2.36-2.83)), with a linear trend from least to most deprived 
areas across all regions in England.  
 
Conclusions The low prevalence of ADHD in medical records may indicate considerable 
under-diagnosis. Higher rates in more disadvantaged areas indicates greater need for 
services in those areas. 
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Introduction 
The community prevalence of attention-deficit/hyperactivity disorder (ADHD) is 3-5% in 
England1. However, the clinically recorded prevalence is much lower (<1%)2 3. Estimates of 
how this varies by deprivation and region are lacking. This cohort study aims to address this 
gap and inform development of health and education services. 
 
Methods 
Data source 
 
We used the General Practice (GP) medical records linked to hospital episodes statistics 
(HES) data from the Clinical Practice Research Datalink (CPRD) from 370 GP practices, 
which represents approximately 4% of the UK population4. These data are broadly 
representative of the UK population and contain information on consultations with GPs, 
hospital admissions, diagnoses and prescriptions4. 
 
Defining the population with ADHD 
 
We extracted medical records for children and young people (CYP) aged 3-17 years 
registered before June 2013 with at least one diagnosis code or prescription for ADHD. We 
took the latest of the date of: third birthday; diagnosis; registration with the practice (in CYP 
diagnosed before registration); or 1st January 1998 (the first full year of the CPRD-HES link) 
as the date when ADHD was first known to the GP. We took the earliest of the date when 
the: CYP left the practice or died; practice stopped participating in the CPRD; CYP turned 18 
years; or 31st December 2012 (the last complete year that CPRD-HES linked data were 
available), as the last date of follow-up. 
 
Estimating prevalence – numerators 
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To calculate the frequency of recorded ADHD in 2012, CYP were required to have received 
the diagnosis on or prior to 1st July and to be registered with the GP on 1st July. The number 
of CYP known to have ADHD by 1st July in 2012 was counted overall and by: age, sex, 
strategic health authority region and social deprivation quintile (English index of multiple 
deprivation (IMD) score 2010, at lower super output area level, based on home postcode). 
The IMD score comprises seven domains: income, employment, health and disability, 
barriers to housing and services, living environment and crime. 
 
Denominators 
 
We extracted medical records from the CPRD for CYP registered before 31st December 
2012. CYP who were: aged from 3-17 years old; registered with the practice and alive, 
between 1st January 2012 and 31st December 2012 were counted in the denominator. The 
number of CYP registered in the CPRD on 1st July in 2012 was counted overall and by age, 
sex, region and deprivation). 
 
Prevalence estimates 
 
Prevalence rates for 2012 were estimated assuming a Poisson distribution and described 
overall, by sex, age, region and deprivation. We assessed whether prevalence by age varied 
by sex and whether deprivation gradients varied by region by adding interaction terms to the 
model assessing significance using a likelihood ratio test (LRT). 
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Sensitivity analyses and subgroup analyses 
 
To explore how altering the definition of ADHD affects estimates of recorded prevalence, we 
described subgroups reflecting at least one drug code or at least one diagnosis code; at 
least two drug codes and at least two diagnosis codes; at least one drug code; no drug 
codes.  
 
Ethics 
 
Approval was obtained from CPRD’s independent scientific advisory committee (ISAC) 
(Protocol reference 12_128R). 
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Results 
There were 5,196 CYP with ADHD and 490,016 without (Table 1). In 2012, the recorded 
prevalence (95%CI) of ADHD was 1.06 (1.03-1.09) %. Boys had a five-fold higher 
prevalence than girls (1.74 % vs. 0.35 %, PRR 4.98 (4.62-5.36) %). The prevalence was 
highest in 15 to 17-year-olds (1.91 (1.82-1.99) %) and lowest in 3 to 4-year-olds (0.01 
(0.002-0.02) %). The relationship between prevalence and age did not differ significantly by 
sex (LRT p=0.09). Prevalence rates increased with increasing deprivation, being two-fold 
higher in CYP from the most compared with the least deprived areas (1.38 % vs 0.73 %, 
PRR 2.58 (2.36-2.83) %; test for linear trend p<0.001). There was considerable geographic 
variation, with higher prevalence in the South East and East regions, compared to Yorkshire 
and Humber (1.55 % and 1.34 % vs. 0.56 %, PRR 3.13 (2.46-3.99) and 2.80 (2.19-2.00)), 
respectively. Varying definitions of ADHD did not alter prevalence patterns by sex, age, 
deprivation or region (online supplementary table). 
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Table 1: The recorded prevalence, crude and adjusted prevalence rate ratio (PRR) of ADHD in 2012 
 
Characteristic £ADHD £No ADHD Prevalence % (95% CI) PRR 95% CI $Adjusted 
PRR 
95% CI P-value 
Overall 5,196 490,016 1.06 (1.03 -1.09) - - - 
Sex Female 
Male 
841 240,034 0.35 (0.33 -0.37) 1 1 p<0.001& 
4,355 249,982 1.74 (1.69 -1.79) 4.97 (4.62 -5.35) 4.98 (4.62 -5.36)  
Age group                       3-4 
5-9 
10-14 
15-17 
$$ 69,713 0.01 (0.002 -0.02) 1 1 p<0.001# 
830 163,834 0.51 (0.47 -0.54) 70.6 (29.3 -170.1) 71.7 (29.8 -173)  
2,467 157,090 1.57 (1.51 -1.63) 219 (91.1 -527) 226 (93.9 -543)  
1,894 99,379 1.91 (1.82 -1.99) 266 (110 -639) 275 (114 -662)  
DeprivationLeast deprived 
2nd least deprived 
Medium deprivation 
2nd most deprived 
Most deprived 
Data missing 
870 118,422 0.73 (0.69 -1.79) 1 1 p<0.001# 
926 99,463 0.93 (0.87 -0.99) 1.27 (1.16 -1.39) 1.36 (1.23 -1.49)  
908 86,374 1.05 (0.98 -1.12) 1.43 (1.30 -1.57) 1.58 (1.44 -1.74)  
1,169 90,230 1.30 (1.22 -1.37) 1.76 (1.62 -1.93) 2.10 (1.92 -2.30)  
1,211 87,564 1.38 (1.31 -1.46) 1.88 (1.73 -2.05) 2.58 (2.36 -2.83)  
112 7,963 1.41 (1.16 -1.69) 1.91 (1.57 -2.33) 2.53 (2.08 -3.08)  
Region          East Midlands 
East of England 
London 
North East 
North West 
South Central 
South East Coast 
South West 
West Midlands 
Yorkshire & Humber 
79 7,480 1.06 (0.84 -1.32) 1.90 (1.38 -2.62) 1.95 (1.42 -2.69) p<0.001& 
698 51,995 1.34 (1.24 -1.45) 2.41 (1.89 -3.08) 2.80 (2.19 -2.00)  
630 83,266 0.76 (0.70 -0.82) 1.36 (1.06 -1.74) 1.36 (1.06 -1.74)  
111 11,165 0.99 (0.82 -1.20) 1.79 (1.33 -2.41) 1.54 (1.15 -2.08)  
717 80,541 0.89 (0.83 -0.96) 1.60 (1.25 -2.04) 1.48 (1.16 -1.89)  
860 67,269 1.28 (1.19 -1.37) 2.30 (1.80 -2.93) 2.70 (2.12 -3.44)  
1,046 67,691 1.55 (1.45 -1.64) 2.78 (2.18 -3.53) 3.13 (2.46 -3.99)  
534 54,875 0.97 (0.89 -1.06) 1.75 (1.37 -2.24) 1.79 (1.39 -2.29)  
450 52,969 0.85 (0.77 -0.93) 1.53 (1.19 -1.96) 1.56 (1.21 -2.00)  
71 12,765 0.56 (0.43 -0.70) 1 1  
£Number of children and young people in 2012 
$Adjusted for the other variables in the table 
&P value for likelihood ratio test comparing the adjusted model with the variable to a model without 
$$Frequencies less than 10 not displayed to protect anonymity 
#P value for test for linear trend adjusting for other variables in the table 
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The social gradient in ADHD prevalence was evident within all regions and also varied 
significantly between regions (Figure 1, test for interaction p<0.001). The steepest social 
gradient (comparing most to least deprived areas) was in the East of England (PRR 3.43 
(2.70-4.37)) and the smallest gradient in London (PRR 1.38 (1.04-1.83)). 
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Discussion 
The recorded prevalence of ADHD in CYP (1.06%) in 2012 was considerably lower than 
community prevalence estimates1. Recorded prevalence estimates worldwide vary from 
0.06% to 13%, with higher estimates originating from the USA5. The prevalence was double 
in the most compared to the least deprived areas with a linear trend across all regions in 
England. The greatest inequality was within the East of England region and the least within 
London.  
 
Our low prevalence estimate suggests that there are many CYP in the population with 
undiagnosed ADHD. This is supported by findings from the British Child and Adolescent 
Mental Health Survey1, which reported ADHD prevalence amongst 5-15 year-olds of 2.23%. 
Under-diagnosis is important as it precludes receipt of appropriate child and parental 
support, educational support and behavioural and pharmacological treatment for ADHD. This 
may be particularly relevant as children transition from primary to secondary school and 
independent learning is increasingly required. As recorded prevalence of ADHD increases 
with age, and we included children aged under five, this may partly explain our low 
prevalence estimate. It is also possible that secondary care ADHD diagnoses are not being 
recorded in primary care records. However, systematic reviews demonstrate accurate 
recording of secondary care diagnoses in primary care records and high validity across a 
wide range of diagnoses, so this is unlikely to explain much of the difference in prevalence 
rates6 7.  
 
Worldwide studies of community prevalence of ADHD suggest CYP from disadvantaged 
families are 1.5 to 4 times more likely to have ADHD symptoms compared to those from 
more advantaged families8. This is consistent with Millennium Cohort Study (MCS) findings 
of strong associations between multiple measures of socio-economic disadvantage and 
parent-reported diagnosed prevalence of ADHD9. This may represent true differences in the 
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prevalence of ADHD, differential symptom reporting or differential access to services to 
diagnose and treat ADHD. The MCS found similar associations between parent or teacher 
reported ADHD symptoms and socio-economic disadvantage, suggesting that clinical 
labelling bias does not explain the social gradient9. Potential explanations for the social 
gradient, include differential exposures to multiple material, psychosocial and environmental 
risk factors before or around the time of birth or in childhood, as well as genetic or 
developmental contributions9. Genetic susceptibility may also play a role, with some 
individuals being more susceptible to adverse, or supportive, environmental exposures10. 
 
Our findings suggest greater need for health and educational services for CYP with ADHD in 
more disadvantaged areas and can inform the development and commissioning of 
appropriate services, with our figures being understood as conservative estimates. Future 
research is needed to explore under-diagnosis or under-recording of ADHD in CYP and 
mechanisms by which socio-economic disadvantage impacts on ADHD prevalence. 
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Figure 1 Prevalence of ADHD by area-level deprivation for each region 
